Evogene Ltd. EVGN
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 60.39% | -1,343.33% | 17.64% | 33.03% | 39.12% |
| Total Depreciation and Amortization | -32.99% | -40.36% | 228.33% | -53.80% | 2.48% |
| Total Amortization of Deferred Charges | -100.00% | 0.00% | -- | -- | -- |
| Total Other Non-Cash Items | -217.38% | 142.08% | 241.53% | -263.98% | 180.79% |
| Change in Net Operating Assets | -94.24% | 41.01% | 744.74% | 17.68% | -204.19% |
| Cash from Operations | 14.21% | 41.11% | 57.82% | -26.08% | 38.82% |
| Capital Expenditure | -800.00% | 98.14% | 96.00% | 14.18% | 4.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 559.51% | 12.58% | -130.54% | 45.07% | 1,801.48% |
| Cash from Investing | 567.14% | 17.18% | -130.81% | 43.95% | 16,663.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -12.20% | 57.10% | 65.69% | 36.80% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4,801.92% | -218.27% | -1,140.00% | 90.65% | -100.58% |
| Cash from Financing | -144.25% | -24.27% | 2,847.68% | 56.68% | -23.30% |
| Foreign Exchange rate Adjustments | -111.11% | 228.57% | 228.57% | -11.11% | 71.13% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.48% | 83.99% | 134.31% | 11.87% | 137.15% |